Influence of neuroleptic drugs and apomorphine on dopamine-sensitive adenylate cyclase of retina.
D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002417:Cattle; D002746:Chlorpromazine / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D004298:Dopamine / Q000494:pharmacology*; D004789:Enzyme Activation / Q000187:drug effects; D004878:Ergotamine / Q000494:pharmacology; D005476:Fluphenazine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010759:Phosphorus Isotopes; D011433:Propranolol / Q000494:pharmacology; D012160:Retina / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D014149:Tranquilizing Agents / Q000494:pharmacology*
D000067956:Adenylyl Cyclase Inhibitors; D010759:Phosphorus Isotopes; D014149:Tranquilizing Agents; D011433:Propranolol; D000242:Cyclic AMP; D006220:Haloperidol; D001058:Apomorphine; D004878:Ergotamine; D005476:Fluphenazine; D002746:Chlorpromazine; D004298:Dopamine; D010646:Phentolamine